Reeves Karen 4
4 · Kiromic Biopharma, Inc. · Filed Jul 5, 2022
Insider Transaction Report
Form 4
Reeves Karen
Director
Transactions
- Award
Stock Option (Right to Buy)
2022-06-30+183,600→ 183,600 totalExercise: $0.43Exp: 2032-06-30→ Common Stock (183,600 underlying)
Footnotes (1)
- [F1]The stock options vest according to the following schedule: (a) 50% of the options vest on June 30, 2022, (b) 25% of the options vest on September 30, 2022, and (c) the remaining 25% of the options vest on December 31, 2022.